000 01167 a2200313 4500
005 20250517234703.0
008 ####s 0 0 eng d
022 _a1432-0843
024 7 _a10.1007/s00280-018-3674-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBanerji, Udai
245 0 0 _aCorrection to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_cNov 2018
300 _a911-912 p.
_bdigital
500 _aPublication Type: Published Erratum
700 1 _aSain, Nivedita
700 1 _aSharp, Swee Y
700 1 _aValenti, Melanie
700 1 _aAsad, Yasmin
700 1 _aRuddle, Ruth
700 1 _aRaynaud, Florence
700 1 _aWalton, Michael
700 1 _aEccles, Suzanne A
700 1 _aJudson, Ian
700 1 _aJackman, Ann L
700 1 _aWorkman, Paul
773 0 _tCancer chemotherapy and pharmacology
_gvol. 82
_gno. 5
_gp. 911-912
856 4 0 _uhttps://doi.org/10.1007/s00280-018-3674-9
_zAvailable from publisher's website
999 _c28794321
_d28794321